Exponent, Inc. $EXPO Shares Sold by Axiom Investors LLC DE

Key Points

• Axiom Investors LLC DE has sold over 58,000 shares of Exponent, Inc., reducing its stake by 49.1%, leaving it with 60,333 shares valued at approximately $4.89 million.
• Exponent reported earnings of $0.52 per share for the last quarter, surpassing analyst expectations and showing a 7.3% year-over-year revenue growth, totaling $132.87 million.
• The company announced a quarterly dividend of $0.30 per share, with a yield of 1.7%, set to be paid to shareholders on September 19th.

Axiom Investors LLC DE trimmed its position in Exponent, Inc. (NASDAQ:EXPO - Free Report) by 49.1% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 60,333 shares of the business services provider's stock after selling 58,234 shares during the period. Axiom Investors LLC DE owned approximately 0.12% of Exponent worth $4,891,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of EXPO. Millennium Management LLC grew its position in Exponent by 543.1% in the 1st quarter. Millennium Management LLC now owns 305,230 shares of the business services provider's stock valued at $24,742,000 after buying an additional 257,766 shares during the last quarter. Cubist Systematic Strategies LLC purchased a new position in Exponent in the 1st quarter valued at $15,349,000. Geneva Capital Management LLC grew its position in Exponent by 11.2% in the 1st quarter. Geneva Capital Management LLC now owns 1,745,828 shares of the business services provider's stock valued at $141,517,000 after buying an additional 176,152 shares during the last quarter. Jacobs Levy Equity Management Inc. purchased a new position in Exponent in the 1st quarter valued at $12,686,000. Finally, Nuveen LLC purchased a new stake in shares of Exponent during the 1st quarter worth $10,828,000. 92.37% of the stock is currently owned by hedge funds and other institutional investors.

Exponent Price Performance

Shares of NASDAQ EXPO traded down $0.90 during trading on Friday, hitting $70.05. 254,323 shares of the company were exchanged, compared to its average volume of 486,854. The company has a market cap of $3.54 billion, a price-to-earnings ratio of 35.03 and a beta of 0.94. Exponent, Inc. has a 1 year low of $63.81 and a 1 year high of $115.75. The firm's fifty day moving average price is $71.62 and its 200 day moving average price is $76.28.

Exponent (NASDAQ:EXPO - Get Free Report) last issued its earnings results on Thursday, July 31st. The business services provider reported $0.52 EPS for the quarter, topping the consensus estimate of $0.48 by $0.04. The company had revenue of $132.87 million for the quarter, compared to analyst estimates of $130.82 million. Exponent had a net margin of 18.35% and a return on equity of 24.19%. The business's revenue was up 7.3% on a year-over-year basis. During the same period in the previous year, the firm earned $0.57 EPS. On average, research analysts forecast that Exponent, Inc. will post 1.98 earnings per share for the current year.

Exponent Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, September 19th. Shareholders of record on Friday, September 5th will be given a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a dividend yield of 1.7%. The ex-dividend date is Friday, September 5th. Exponent's payout ratio is presently 60.00%.

Insider Buying and Selling at Exponent

In other Exponent news, CEO Catherine Corrigan sold 4,896 shares of the business's stock in a transaction on Thursday, August 14th. The shares were sold at an average price of $71.09, for a total transaction of $348,056.64. Following the sale, the chief executive officer directly owned 81,342 shares in the company, valued at approximately $5,782,602.78. The trade was a 5.68% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, VP Joseph Sala sold 1,595 shares of the business's stock in a transaction on Tuesday, August 12th. The stock was sold at an average price of $70.64, for a total transaction of $112,670.80. The disclosure for this sale can be found here. 1.60% of the stock is currently owned by insiders.

Exponent Profile

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.